09939 KINTOR PHARMA-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.03X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 6.8% | Net Margin | N/A |
| Total Debt/Equity | 45.2% | Return on Equity | N/A |
| Price/Book | 3.45X | Return on Assets | N/A |
| (HKD 2.410) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -165.15 | -1,169.24 | -1,070.04 | -1,029.97 | -603.25 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +85.9 | -9.3 | -3.9 | -70.7 | -132.0 |
| Earnings Per Share (HKD) | -0.383 | -2.725 | -2.842 | -2.89 | -1.95 |
| Earnings Per Share Growth (%) | +85.9 | +4.1 | +1.7 | -48.2 | +100.0 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.699 | 1.128 | 3.746 | 5.223 | 4.845 |
| Auditors' Opinion | Unqualified # | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 5.984 | 0 | N/A | 0 |
| Operating Result | -83.064 | -71.51 | +16.2 | -212.485 |
| Associates | -0.481 | 0 | N/A | -0.131 |
| Profit Before Taxation | -83.545 | -71.475 | +16.9 | -212.618 |
| Taxation | -0.277 | 0.018 | -1,638.9 | -0.507 |
| Profit /( Loss) After Taxation | -83.268 | -71.493 | +16.5 | -212.111 |
| Net Profit | -83.268 | -71.493 | +16.5 | -212.111 |
| Earnings Per Share () | -0.2102 | -0.1785 | +17.8 | -0.5343 |
| Announcement Date | 2025-08-28 | 2024-08-26 | NA | 2023-08-28 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
